Company/Estimate
- (PCP)/1.72
- (ETN)/1.71
- (WB)/.33
- (JEC)/.71
- (BAC)/.21
- (RF)/.29
- (BJS)/.59
- (JNJ)/.86
- (UNH)/.92
- (KEY)/-.03
- (CSX)/.64
- (ABK)/-3.86
- (DD)/.50
- (AKS)/.58
- (DOX)/.56
- (TXN)/.52
- (ACF)/.24
- (NSC)/.90
- (WAT)/1.06
- (FIC)/.46
- (NWK)/.06
Abbott Laboratories (ABT): The drugmaker said its top- selling drug, Humira, won U.S. approval to treat moderate to severe forms of the skin disease psoriasis. The stock fell 32 cents to $59.43 in regular trading.
Target Corp. (TGT): The second-largest U.S. discount chain said sales at stores open at least a year may be at the low end of its forecast in January. Same-store sales will range from a 1 percent decrease to a 1 percent gain in the four weeks through Feb. 2, the company said. The shares added 16 cents to $50.10 in regular trading.WellCare Health Plans Inc. (WCG): The insurer under FBI investigation said it received U.S. approval to sell its Medicare health plans for the elderly and disabled in four additional counties in New York state. The stock rose 46 cents to $53.86 in regular trading.
Watch FDX, LVS, ATI, MHK, BDK, MAN for short breakdowns.
-MM
